File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1080/17425247.2020.1788541
- Scopus: eid_2-s2.0-85088048673
- PMID: 32619149
- WOS: WOS:000555213100001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Release mechanisms and applications of drug delivery systems for extended-release
Title | Release mechanisms and applications of drug delivery systems for extended-release |
---|---|
Authors | |
Keywords | Extended release controlled release degradation diffusion erosion |
Issue Date | 2020 |
Publisher | Informa Healthcare. The Journal's web site is located at http://www.expertopin.com/loi/edd |
Citation | Expert Opinion on Drug Delivery, 2020, v. 17 n. 9, p. 1289-1304 How to Cite? |
Abstract | Introduction: Drug delivery systems with extended-release profiles are ideal in improving patient compliance with enhanced efficacy. To develop devices capable of a prolonged delivery kinetics, it is crucial to understand the various underlying mechanisms contributing to extended drug release and the impact thereof on modulating the long-term performance of such systems in a practical application environment.
Areas covered: This review article intends to provide a comprehensive summary of release mechanisms in extended-release drug delivery systems, particularly polymer-based systems; however, other material types will also be mentioned. Selected current research in the delivery of small molecule drugs and macromolecules is highlighted. Emphasis is placed on the combined impact of different release mechanisms and drug properties on the long-term release kinetics in vitro and in vivo.
Expert opinion: The development of drug delivery systems over an extended duration is promising but also challenging when considering the numerous interrelated delivery-related parameters. Achieving a well-controlled extended drug release requires advanced techniques to minimize burst release and lag phase, a better understanding of the dynamic interrelationship between drug properties and release profiles over time, and a thorough elucidation of the impact of multiple in vivo conditions to methodically evaluate the eventual clinical efficacy. |
Persistent Identifier | http://hdl.handle.net/10722/304679 |
ISSN | 2021 Impact Factor: 8.129 2020 SCImago Journal Rankings: 1.084 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wang, S | - |
dc.contributor.author | Liu, R | - |
dc.contributor.author | Fu, Y | - |
dc.contributor.author | Kao, WJ | - |
dc.date.accessioned | 2021-10-05T02:33:35Z | - |
dc.date.available | 2021-10-05T02:33:35Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Expert Opinion on Drug Delivery, 2020, v. 17 n. 9, p. 1289-1304 | - |
dc.identifier.issn | 1742-5247 | - |
dc.identifier.uri | http://hdl.handle.net/10722/304679 | - |
dc.description.abstract | Introduction: Drug delivery systems with extended-release profiles are ideal in improving patient compliance with enhanced efficacy. To develop devices capable of a prolonged delivery kinetics, it is crucial to understand the various underlying mechanisms contributing to extended drug release and the impact thereof on modulating the long-term performance of such systems in a practical application environment. Areas covered: This review article intends to provide a comprehensive summary of release mechanisms in extended-release drug delivery systems, particularly polymer-based systems; however, other material types will also be mentioned. Selected current research in the delivery of small molecule drugs and macromolecules is highlighted. Emphasis is placed on the combined impact of different release mechanisms and drug properties on the long-term release kinetics in vitro and in vivo. Expert opinion: The development of drug delivery systems over an extended duration is promising but also challenging when considering the numerous interrelated delivery-related parameters. Achieving a well-controlled extended drug release requires advanced techniques to minimize burst release and lag phase, a better understanding of the dynamic interrelationship between drug properties and release profiles over time, and a thorough elucidation of the impact of multiple in vivo conditions to methodically evaluate the eventual clinical efficacy. | - |
dc.language | eng | - |
dc.publisher | Informa Healthcare. The Journal's web site is located at http://www.expertopin.com/loi/edd | - |
dc.relation.ispartof | Expert Opinion on Drug Delivery | - |
dc.rights | Accepted Manuscript (AM) i.e. Postprint This is an Accepted Manuscript of an article published by Taylor & Francis in [JOURNAL TITLE] on [date of publication], available online: http://www.tandfonline.com/[Article DOI]. | - |
dc.subject | Extended release | - |
dc.subject | controlled release | - |
dc.subject | degradation | - |
dc.subject | diffusion | - |
dc.subject | erosion | - |
dc.title | Release mechanisms and applications of drug delivery systems for extended-release | - |
dc.type | Article | - |
dc.identifier.email | Kao, WJ: wjkao@hku.hk | - |
dc.identifier.authority | Kao, WJ=rp02076 | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1080/17425247.2020.1788541 | - |
dc.identifier.pmid | 32619149 | - |
dc.identifier.scopus | eid_2-s2.0-85088048673 | - |
dc.identifier.hkuros | 326389 | - |
dc.identifier.volume | 17 | - |
dc.identifier.issue | 9 | - |
dc.identifier.spage | 1289 | - |
dc.identifier.epage | 1304 | - |
dc.identifier.isi | WOS:000555213100001 | - |
dc.publisher.place | United Kingdom | - |